alzheimer’s
Emil Chuang, Chief Medical Officer at Intrinsic Medicine, explores the growing understanding of gut-brain axis disorders and the potential of Human Milk Oligosaccharides (HMOs) in their treatment.
The findings suggest that gut microbes and LPC are potential therapeutic targets for Alzheimer's disease.
Arpana Church (UCLA): ‘We’re hoping to better understand the role of dietary polyphenols in slowing the development of cognitive decline and how this is all influenced by the gut microbiome’.
Understanding how gut microbes are linked to preclinical Alzheimer’s disease could help to identify markers of disease risk.
The findings may inform strategies to modulate the gut microbiota as a way to prevent or treat neurodegeneration.
Periodontitis might be associated with cognitive decline, suggesting a possible etiopathologic role in Alzheimer's disease.
Specific strains of the gut commensal Faecalibacterium prausnitzii may help ease the cognitive difficulties associated with Alzheimer’s disease. A new study published in Cell Reports Medicine claims.
A study published in Science Advances suggests that optimizing the gut microbiota can inhibit the development of Alzheimer’s disease.
According to a new study published in The Journal of Experimental Medicine, antibiotic treatment reduces Alzheimer’s disease symptoms.
